Acute Promyelocytic Leukemia-overview of CLSG/CGEL Practice guidelines

When: Monday, May 27, 2024 at 7:00PM EST  Where: Zoom – link will be provided upon registration Faculty : Brian Leber, Juravinski Cancer Centre/McMaster University Kristjian Paulson, Cancer Care Manitoba/University of Manitoba Andre Schuh, Princess Margaret Cancer Centre/University of Toronto Objectives: Practical management issues-ongoing questions Oral arsenic: time to move forward? Canadian APL Registry- update […]

Optimizing Asparaginase Use in Adult ALL Therapy: Presentation and Discussion

When: Monday May 6th  at 7:00 PM EST Where: Zoom - link will be provided upon registration Faculty : Andre C Schuh, MD Princess Margaret Cancer Center Professor, University of Toronto Objectives: To understand the mechanism of action and importance of asparaginase in ALL treatment To compare and contrast the various asparaginase formulations available in […]

A Clinician’s Guide to Optical Genome Mapping (OGM) – a Revolution in Acute Leukemia Diagnosis

Optical Genome Mapping is a new genome-wide, high-resolution assay for structural, chromosomal variation (i.e. structural and numeric changes). Its use is growing in Canada and around the world, especially in hematologic malignancies. With the higher resolution offered by OGM, we will see improved genetic classification for patients, and likely also an increase in novel observations.

Canadian Acute Leukemia Registry: Generating Real World Data

Evolving Role of FLT3 Analysis in AML Diagnosis and Management: Presentation and Discussion When: Monday, June 19, 2023, 7:00 PM EST Where: Zoom – link will be provided upon registration Faculty : Kristjan Paulson CancerCare Manitoba Department of Medicine

Evolving Role of FLT3 Analysis in AML Diagnosis and Management: Presentation and Discussion

Evolving Role of FLT3 Analysis in AML Diagnosis and Management: Presentation and Discussion When: Monday, May 29, 2023, 7:00 PM EST Where: Zoom – link will be provided upon registration Faculty : Julie Bergeron, MD Hôpital Maisonneuve-Rosemont, Montreal, QC José-Mario Capo-Chichi, PhD University Health Network, Toronto, ON Hubert Tsui, MD Sunnybrook Health Sciences Centre, Toronto, ON Questions […]

Maintenance Therapy in AML Comes of Age: Presentation and Discussion

While maintenance therapy has long been a standard of care in ALL and in APL, until recently there has been little evidence to support its use in non-APL AML. In this webinar we will review recent data that have led to the approval of oral azacitidine for AML maintenance, will define the optimal use of oral azacitidine for this indication, and will discuss the evolving role of maintenance therapy in FLT3-mutated AML.

CLSG/GCEL Update for Pharma

The first Annual General Meeting (AGM) of the Canadian Leukemia Study Group is being held in January and we would like to share the proceedings with you.

CLSG Pharmacy Interest Group Initial Meeting

The purpose of the Pharmacy Interest Group groups is to address the specific needs of Acute Leukemia Pharmacy practice, within the mandate of CLSG, which in brief, is to improve Acute Leukemia care in Canada.

CLSG/GCEL Annual General Meeting

The first Annual General Meeting (AGM) of the Canadian Leukemia Study Group/Groupe Canadien D’Étude Sur La Leucémie will be held on Monday, January 24, 2022 from 5:30 - 7:30 PM EST

CLSG/GCEL Launch Webinar 3

The founding goals of CLSG are to advance the diagnosis and treatment of leukemia in Canada, by identifying diagnostic and management best practices, promoting Canada-wide standards-of-care, fostering clinical and basic leukemia research, and improving new drug access.

CLSG/GCEL Launch Webinar 2

The founding goals of CLSG are to advance the diagnosis and treatment of leukemia in Canada, by identifying diagnostic and management best practices, promoting Canada-wide standards-of-care, fostering clinical and basic leukemia research, and improving new drug access.

Member Login